Liang Xu

Collaboration Map View Statistics Email Alert RSS Feed

Full Name

Liang Xu

(not current staff)

Variants

Xu Liang

Main Affiliation

CANCER SCIENCE INSTITUTE OF SINGAPORE

Faculty

SPECIALITY RESEARCH INSTITUTES/CENTRES

csixl@nus.edu.sg

Refined By:

Policy: Open

Department: CANCER SCIENCE INSTITUTE OF SINGAPORE

Department: DUKE-NUS MEDICAL SCHOOL

Results 1-5 of 5 (Search time: 0.007 seconds).

Refman EndNote Bibtex RefWorks Excel CSV PDF Send via email

	Issue Date	Title	Author(s)
1	2018	Functional genome-wide screening identifies targets and pathways sensitizing pancreatic cancer cells to dasatinib	Chien W. ; Sudo M. ; Ding L.-W. ; Sun Q.-Y. ; Wuensche P.; Lee K.L. ; Hattori N.; Garg M. ; Xu L. ; Zheng Y.; Gery S.; Wongphayak S. ; Yang H. ; Baloglu E.; Shacham S.; Kauffman M.; Mori S. ; Phillip Koeffler H.
2	2020	Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor	Lim, S.-L.; Xu, L. ; Han, B.-C.; Shyamsunder, P. ; Chng, W.-J. ; Phillip Koeffler, H.
3	2017	Mutational profiling of acute lymphoblastic leukemia with testicular relapse	Ding, L.-W ; Sun, Q.-Y ; Mayakonda, A ; Tan, K.-T ; Chien, W ; Lin, D.-C ; Jiang, Y.-Y ; Xu, L ; Garg, M ; Lao, Z.-T ; Lill, M.; Yang, H ; Yeoh, A.E.J ; Koeffler, H.P
4	2018	Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines 11 Medical and Health Sciences 1107 Immunology	Tan, K.-T ; Ding, L.-W ; Sun, Q.-Y ; Lao, Z.-T ; Chien, W ; Ren, X; Xiao, J.-F ; Loh, X.Y ; Xu, L ; Lill, M; Mayakonda, A ; Lin, D.-C; Yang, H ; Koeffler, H.P
5	2019	Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations	Lim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P.